返回 
加入收藏
中国人群药物致急性肾损伤的系统评价
x
请在关注微信后，向客服人员索取文件
| 篇名： | 中国人群药物致急性肾损伤的系统评价 |
| TITLE： | |
| 摘要： | 目的：研究我国药物致急性肾损伤（DIAKI）的临床现状和预后影响因素，为DIAKI的早期发现、早期干预和改善预后提供参考。方法：计算机检索PubMed、Embase、CochraneLibrary、中国知网、万方数据库和维普网，检索DIAKI相关的临床研究，检索时限均为从各库建库起至2020年4月16日。对纳入研究进行资料提取和质量评价后，对结果进行描述性分析，并采用RevMan5.3软件进行Meta分析。结果：共纳入29项研究，合计1870例患者。DIAKI例数占同期发生急性肾损伤（AKI）总例数的32.2％（877/2721）。涉及药物以抗菌药物为主，占47.5％（773/1629）；例数排名前5位的药物类别分别为氨基糖苷类抗生素、利尿剂或脱水剂、头孢菌素类抗生素、非甾体抗炎药和中药。DIAKI病理类型以急性间质性肾炎为主，占51.9％（70/135）。DIAKI患者病死率为14.4％（240/1677）；共有70.4％（1176/1670）的患者肾功能痊愈。与保守治疗比较，接受透析治疗的患者病死率显著更低[OR＝0.30，95％CI（0.10，0.91），P＝0.003]；与无贫血的患者比较，合并贫血状态的患者肾功能恢复显著延迟[OR＝0.25，95％CI（0.09，0.65），P＝0.004]；而更低的视黄醇结合蛋白水平与肾功能快速恢复显著相关[MD＝－15.84，95％CI（－22.34，－9.34），P＜0.01]。结论：医务人员需要不断加强抗菌药物管理，谨慎使用致AKI药物；对于发生DIAKI的患者，尽早给予透析治疗可能有助于降低其病死率；及时纠正DIAKI患者的基础贫血状态，有助于患者肾功能的快速恢复；更低的视黄醇结合蛋白水平可能是预测患者肾功能快速恢复的潜在生物标志物。 |
| ABSTRACT： | OBJECTIVE：To study clinical situation and influential factors for prognosis of drug-i nduced acute kidney injury （DIAKI）in Chinese population ，and to provide reference for early detection ，early intervention and prognosis improvement of DIAKI. METHODS ：Retrieved from PubMed ，Embase，Cochrane Library ，CNKI，Wanfang database and VIP ，clinical studies related to DIAKI were collected during the inception to Apr. 16th，2020. After the data extraction and quality evaluation of included studies，the results were analyzed descriptively ，and Meta-analysis was carried out by Rev Man 5.3 software. RESULTS ：A total of 29 studies were included ，including 1 870 patients. The results showed that DIAKI accounted for 32.2％（877/2 721）of the patients developed AKI in the same period. Antibacterial drugs were the main cause of DIAKI ，accounting for 47.5％（773/1 629）. The top five drugs by case number were classified as aminoglycoside antibiotics ，diuretics or dehydrating agents ，cephalosporin antibiotics，non-steroidal anti-inflammatory drugs and traditional Chinese medicine. The pathological type of DIAKI was mainly acute interstitial nephritis ，accounting for 51.9％（70/135）. The mortality of DIAKI patients was 14.4％（240/1 677）. A total of 70.4％（1 176/1 670）of patients had renal recovery. Compared with conservative treatment ，the mortality of patients receiving dialysis treatment was significantly lower [OR ＝0.30，95％CI（0.10，0.91），P＝0.003]. Compared with patients without anemia ， patients with anemia had a significantly delayed renal recovery [OR ＝0.25，95％CI（0.09，0.65），P＝0.004]. Lower levels of retinol binding protein was significantly related to rapid renal recovery [MD ＝－15.84，95％CI（－22.34，－9.34），P＜0.01]. CONCLUSIONS：Clinicians need to continuously strengthen antibiotic management and use drugs that induce AKI with caution. For patients with DIAKI ，receiving dialysis treatment as soon as possible may help reduce mortality. Timely correction of the basic anemia status of patients with DIAKI will help patients withrapid renal recovery ，and lower retinol binding protein levels may be a potential biomarker for predicting patients ’rapidrenal recovery. |
| 期刊： | 2021年第32卷第09期 |
| 作者： | 潘坤明，陈灿，江莹，吴薇，许青，李晓宇，吕迁洲 |
| AUTHORS： | |
| 关键字： | 中国；药物致急性肾损伤；系统评价；抗菌药物；预后；影响因素 |
| KEYWORDS： | China； Drug-induced acute kidney injury ； |
| 阅读数： | 221 次 |
| 本月下载数： | 7 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
